Is AVGR a good stock to buy?
REDWOOD CITY, CA / ACCESSWIRE / March 22, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided,...
How many shares of AVGR stock are traded each day?
Apr 11, 2022 · Real-time trade and investing ideas on Avinger Inc AVGR from the largest community of traders and investors.
How much did AGR (AVGR) raise in its IPO?
Mar 30, 2022 · Avinger, Inc. is a commercial-stage medical device company, which engages in the designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease. Its products include Pantheris, Lightbox, Ocelot, Wildcat, Juicebox, and Kittycat.
How much is Avinger stock worth?
Get the latest Avinger Inc (AVGR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Is AVGR a good stock to buy?
Is AVINGER Stock a good buy in 2022, according to Wall Street analysts? The consensus among 1 Wall Street analyst covering (NASDAQ: AVGR) stock is to Strong Buy AVGR stock.
Will AVGR stock go up?
Given the current short-term trend, the stock is expected to rise 451.38% during the next 3 months and, with a 90% probability hold a price between $10.71 and $29.08 at the end of this 3-month period.
What does Avinger Inc do?
Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD).Apr 14, 2022
Is Avinger a buy right now?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avinger in the last twelve months. There are currently 2 buy ratings for t...
How has Avinger's stock price been impacted by COVID-19 (Coronavirus)?
Avinger's stock was trading at $8.60 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organiza...
Are investors shorting Avinger?
Avinger saw a decrease in short interest during the month of February. As of February 15th, there was short interest totaling 3,230,000 shares, a d...
When is Avinger's next earnings date?
Avinger is scheduled to release its next quarterly earnings announcement on Tuesday, March 22nd 2022. View our earnings forecast for Avinger .
How can I listen to Avinger's earnings call?
Avinger will be holding an earnings conference call on Tuesday, March 22nd at 4:30 PM Eastern. Interested parties can register for or listen to the...
How were Avinger's earnings last quarter?
Avinger, Inc. (NASDAQ:AVGR) issued its earnings results on Thursday, November, 11th. The medical device company reported ($1.20) earnings per share...
When did Avinger's stock split? How did Avinger's stock split work?
Avinger shares reverse split on Tuesday, March 15th 2022. The 1-20 reverse split was announced on Tuesday, March 15th 2022. The number of shares ow...
What price target have analysts set for AVGR?
2 analysts have issued 1 year price objectives for Avinger's shares. Their forecasts range from $11.00 to $40.00. On average, they anticipate Aving...
Who are Avinger's key executives?
Avinger's management team includes the following people: Jeffrey M. Soinski , President, Chief Executive Officer & Director Mark B. Weinswig , C...
About Avinger
Headlines
Avinger, Inc. is a commercial-stage medical device company, which engages in the designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease. Its products include Pantheris, Lightbox, Ocelot, Wildcat, Juicebox, and Kittycat. The company was founded by John B.
Premium Research for AVGR
Avinger shares are trading higher. A 510 (k) premarket notification posted on the FDA's site for the company's 'Catheter For Crossing Total Occlusions' showed a decision date of Jan. 6. - Benzinga
Company Summary
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Ideas
Avinger, Inc. is engaged in designing, manufacturing and selling image-guided, catheter-based systems to treat peripheral arterial disease. The company's product consists of Lightbox imaging console, Wildcat, Kittycat, Ocelot, Ocelot PIXL, Ocelot MVRX and Juicebox. Avinger, Inc. is based in Redwood City, California.
Profile
Contextual immersion trading strategy idea. Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe.
Signals & Forecast
Avinger, Inc. is a commercial-stage medical device company, which engages in the designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease. Its products include Pantheris, Lightbox, Ocelot, Wildcat, Juicebox, and Kittycat. The company was founded by John B.
Support, Risk & Stop-loss
A buy signal was issued from a pivot bottom point on Thursday, February 17, 2022, and so far it has risen 3.08%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).
Is Avinger stock A Buy?
Avinger finds support from accumulated volume at $0.24 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Insiders are very negative
Avinger holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.
About Avinger
In the last 1 trades there were . The last trade was done 19 046 days ago by who bough 0 shares.
Golden Star Signal
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe.
Top Fintech Company
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Company Profile
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
Analyst Opinions
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and…
Research Reports
The Equity Summary Score is an accuracy-weighted sentiment derived from the ratings of independent research providers on Fidelity.com. It uses the past relative accuracy of the providers in determining the emphasis placed on any individual opinion. Learn More....
